Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 09.09.2019 1 Ann Neurol 1 Curr Opin Immunol 2 Intern Med 1 J Autoimmun 1 J Immunol 1 J Nephrol 2 J Neuroimmunol 3 J Neurol 1 J Pediatr Endocrinol Metab 3 J Rheumatol 1 Kidney Int 3 Lancet Neurol 1 Nat Rev Neurol 2 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. KRYSKO KM, Henry RG, Cree BAC, Lin J, et al
   Telomere length is associated with disability progression in multiple sclerosis.
   Ann Neurol. 2019 Sep 4. doi: 10.1002/ana.25592.
   PubMed     Text format     Abstract available
   
   

   
   Curr Opin Immunol

2. STEINMAN L, Ho PP, Robinson WH, Utz PJ, et al
   Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity.
   Curr Opin Immunol. 2019;61:46-53.
   PubMed     Text format     Abstract available
   
   

   
   Intern Med

3. KANEKO J, Matsubayashi H, Satoh T, Sato J, et al
   Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm.
   Intern Med. 2019 Sep 3. doi: 10.2169/internalmedicine.3561.
   PubMed     Text format     Abstract available
   
   
4. INADA R, Miyamoto K, Tanaka N, Moriguchi K, et al
   Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis.
   Intern Med. 2019 Sep 3. doi: 10.2169/internalmedicine.3030.
   PubMed     Text format     Abstract available
   
   

   
   J Autoimmun

5. VLACHIOTIS S, Andreakos E
   Lambda interferons in immunity and autoimmunity.
   J Autoimmun. 2019 Aug 31:102319. doi: 10.1016/j.jaut.2019.102319.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

6. KAUSHANSKY N, Bakos E, Becker-Herman S, Shachar I, et al
   Circulating Picomolar Levels of CCL2 Downregulate Ongoing Chronic Experimental Autoimmune Encephalomyelitis by Induction of Regulatory Mechanisms.
   J Immunol. 2019 Sep 4. pii: jimmunol.1900424. doi: 10.4049/jimmunol.1900424.
   PubMed     Text format     Abstract available
   
   

   
   J Nephrol

7. CIFERSKA H, Honsova E, Lodererova A, Hruskova Z, et al
   Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
   J Nephrol. 2019 Sep 5. pii: 10.1007/s40620-019-00640.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

8. ZHANG G, Wang Q, Song Y, Cheng P, et al
   Intravenous immunoglobulin promotes the proliferation of CD4(+)CD25(+) Foxp3(+) regulatory T cells and the cytokines secretion in patients with Guillain-Barre syndrome in vitro.
   J Neuroimmunol. 2019;336:577042.
   PubMed     Text format     Abstract available
   
   
9. SVEINSSON O, Piehl F, Aspegren O, Hietala MA, et al
   Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome.
   J Neuroimmunol. 2019;336:577028.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

10. WAGNER JN, Schwarz G, Puttinger G, Hengsberger AM, et al
    Anti-NMDA receptor encephalitis triggered by epilepsy surgery.
    J Neurol. 2018 May 30. pii: 10.1007/s00415-018-8918.
    PubMed     Text format    
    
    
11. SHEMA-SHIRATZKY S, Gazit E, Sun R, Regev K, et al
    Deterioration of specific aspects of gait during the instrumented 6-min walk test among people with multiple sclerosis.
    J Neurol. 2019 Sep 6. pii: 10.1007/s00415-019-09500.
    PubMed     Text format     Abstract available
    
    
12. CHAMBERLAIN JL, Huda S, Whittam DH, Matiello M, et al
    Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.
    J Neurol. 2019 Sep 3. pii: 10.1007/s00415-019-09498.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Endocrinol Metab

13. STRAKOVA V, Elblova L, Johnson MB, Dusatkova P, et al
    Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing?
    J Pediatr Endocrinol Metab. 2019.
    PubMed     Text format     Abstract available
    
    

    
    J Rheumatol

14. MUKWIKWI ER, Pineau CA, Vinet E, Clarke AE, et al
    Retinal Complications in Systemic Lupus Erythematosus Patients Treated with Antimalarial Drugs.
    J Rheumatol. 2019 Sep 1. pii: jrheum.181102. doi: 10.3899/jrheum.181102.
    PubMed     Text format     Abstract available
    
    
15. SMITHERMAN EA, Huang B, Furnier A, Taylor J, et al
    Quality of care in childhood-onset systemic lupus erythematosus: Report of an intervention to improve cardiovascular and bone health screening.
    J Rheumatol. 2019 Sep 1. pii: jrheum.190295. doi: 10.3899/jrheum.190295.
    PubMed     Text format     Abstract available
    
    
16. SMITH V, Distler O, Cutolo M
    Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?
    J Rheumatol. 2019;46:1061-1063.
    PubMed     Text format    
    
    

    
    Kidney Int

17. FLOEGE J
    A new tool to predict the risk of progression in IgA nephropathy.
    Kidney Int. 2019 Aug 1. pii: S0085-2538(19)30776.
    PubMed     Text format    
    
    

    
    Lancet Neurol

18. MOWRY EM, Corboy JR
    Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis.
    Lancet Neurol. 2019 Sep 3. pii: S1474-4422(19)30333.
    PubMed     Text format    
    
    
19. COMI G, Kappos L, Selmaj KW, Bar-Or A, et al
    Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.
    Lancet Neurol. 2019 Sep 3. pii: S1474-4422(19)30239.
    PubMed     Text format     Abstract available
    
    
20. COHEN JA, Comi G, Selmaj KW, Bar-Or A, et al
    Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
    Lancet Neurol. 2019 Sep 3. pii: S1474-4422(19)30238.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Neurol

21. LEMPRIERE S
    The central vein sign as a clinical diagnostic biomarker for multiple sclerosis.
    Nat Rev Neurol. 2019 Sep 4. pii: 10.1038/s41582-019-0261.
    PubMed     Text format    
    
    

    
    Neurology

22. EIJLERS AJC, Dekker I, Steenwijk MD, Meijer KA, et al
    Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis.
    Neurology. 2019 Sep 4. pii: WNL.0000000000008198.
    PubMed     Text format     Abstract available
    
    
23. BARKHOF F, Kappos L, Wolinsky JS, Li DKB, et al
    Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
    Neurology. 2019 Sep 4. pii: WNL.0000000000008189.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. SHEN H, Ji Y, Xiong Y, Kim H, et al
    Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKalpha pathway shapes autoimmunity and liver and lung homeostasis in mice.
    Proc Natl Acad Sci U S A. 2019 Sep 3. pii: 1901056116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: